$RYAN earnings report

Total Revenue grew 4.7% year-over-year to $790.0 million; Adjusted EBITDAC grew 3.8% year-over-year to $244.4 million; Adjusted Diluted Earnings Per Share grew 8.5% to $0.51 per diluted share. AlphAI read Ryan Specialty Holdings's Third Quarter 2026 filing as mixed. 2 quarters are on record below.

Third Quarter 2026

AlphAI · Earnings readRYAN · Third Quarter 2026 · ended September 30, 2026

Total Revenue grew 4.7% year-over-year to $790.0 million; Adjusted EBITDAC grew 3.8% year-over-year to $244.4 million; Adjusted Diluted Earnings Per Share grew 8.5% to $0.51 per diluted share.

→Mixed quarter

Revenue, net income and adjusted diluted earnings per share increased year over year, while organic revenue growth slowed to 4.0% from 15.0% and Adjusted EBITDAC margin declined to 30.9% from 31.2%.

Revenue
$790M
4.7 % y/y
Q3 2026 Wholesale Brokerage net commissions and fees
$394M
4.6 % y/y
EPS · non-GAAP
$0.51
8.5 % y/y

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q3 2026 Total revenueGAAP$790.0M–4.7 %
Q3 2026 Net commissions and feesGAAP$775.1M–4.8 %
Q3 2026 Fiduciary investment incomeGAAP$14.88M––
Q3 2026 Compensation and benefitsGAAP$484.2M–9.9 %
Q3 2026 General and administrativeGAAP$107.0M–(9.0) %
Q3 2026 AmortizationGAAP$64.28M––
Q3 2026 DepreciationGAAP$4.33M––
Q3 2026 Change in contingent considerationGAAP−$10.66M––
Q3 2026 Total operating expensesGAAP$649.1M–0.8 %
Q3 2026 Operating incomeGAAP$140.8M–27.1 %
Q3 2026 Interest expense, netGAAP$57.26M––
Q3 2026 Income from equity method investmentsGAAP−$11.84M––
Q3 2026 Other non-operating incomeGAAP−$784K––
Q3 2026 Income before income taxesGAAP$96.19M––
Q3 2026 Income tax expense (benefit)GAAP$8.14M––
Q3 2026 Net incomeGAAP$88.05M–40.6 %
Q3 2026 Net income attributable to Ryan Specialty Holdings, Inc.GAAP$36.68M–18.0 %
Q3 2026 Compensation and benefits expense ratioGAAP61.3 %––
Q3 2026 General and administrative expense ratioGAAP13.5 %––
Q3 2026 Net income marginGAAP11.1 %––
Q3 2026 Earnings per shareGAAP$0.30––
Q3 2026 Diluted earnings per shareGAAP$0.29––
Q3 2026 Organic revenue growth ratenon-GAAP4.0 %––
Q3 2026 Adjusted compensation and benefits expensenon-GAAP$443.4M–6.3 %
Q3 2026 Adjusted compensation and benefits expense rationon-GAAP56.1 %––
Q3 2026 Adjusted general and administrative expensenon-GAAP$102.1M–0.3 %
Q3 2026 Adjusted general and administrative expense rationon-GAAP12.9 %––
Q3 2026 Adjusted EBITDACnon-GAAP$244.4M–3.8 %
Q3 2026 Adjusted EBITDAC marginnon-GAAP30.9 %––
Q3 2026 Adjusted net incomenon-GAAP$137.1M–4.1 %
Q3 2026 Adjusted net income marginnon-GAAP17.4 %––
Q3 2026 Adjusted diluted earnings per sharenon-GAAP$0.51–8.5 %
Nine Months Ended September 30, 2026 Total revenueGAAP$2.50B–8.8 %
Nine Months Ended September 30, 2026 Net commissions and feesGAAP$2.46B–9.0 %
Nine Months Ended September 30, 2026 Total operating expensesGAAP$2.09B–9.9 %
Nine Months Ended September 30, 2026 Operating incomeGAAP$415.7M–3.4 %
Nine Months Ended September 30, 2026 Net incomeGAAP$237.0M–29.6 %
Nine Months Ended September 30, 2026 Diluted earnings per shareGAAP$0.74––
Nine Months Ended September 30, 2026 Organic revenue growth ratenon-GAAP7.3 %––
Nine Months Ended September 30, 2026 Adjusted EBITDACnon-GAAP$803.4M–7.9 %
Nine Months Ended September 30, 2026 Adjusted EBITDAC marginnon-GAAP32.1 %––
Nine Months Ended September 30, 2026 Adjusted net incomenon-GAAP$466.6M–10.0 %
Nine Months Ended September 30, 2026 Adjusted diluted earnings per sharenon-GAAP$1.75–15.1 %
Nine Months Ended September 30, 2026 Total cash flows provided by operating activitiesGAAP$306.9M––
Nine Months Ended September 30, 2026 Capital expendituresGAAP−$52.23M––
Twelve Months Ended September 30, 2026 Credit Adjusted EBITDACnon-GAAP$1.09B––

Segments

SegmentRevenueq/qy/y
Q3 2026 Wholesale Brokerage net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$394.3M–4.6 %
Q3 2026 Binding Authority net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$93.01M–3.8 %
Q3 2026 Underwriting Management net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$287.8M–5.4 %
Nine Months Ended September 30, 2026 Wholesale Brokerage net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$1.27B–4.6 %
Nine Months Ended September 30, 2026 Binding Authority net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$303.2M–6.0 %
Nine Months Ended September 30, 2026 Underwriting Management net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$886.6M–17.3 %

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Full Year 2026 outlook

  • NoteOrganic Revenue Growth Rate in the mid-single digits for 2026
  • NoteAdjusted EBITDAC Margin that is down modestly for 2026, as compared to the prior year

Capital returns

  • Returned approximately $173.7 million to shareholders in the third quarter.
  • $150.0 million of Class A common stock repurchases, representing 3.5 million shares.
  • $23.7 million in dividends and distributions.
  • $150.0 million of remaining authorization under its share repurchase program as of September 30, 2026.
  • Quarterly dividend of $0.13 per share declared on October 29, 2026, payable on November 24, 2026 to stockholders of record as of the close of business on November 10, 2026.
  • $0.06 per share of the quarterly dividend will be funded by free cash flow from Ryan Specialty, LLC.

What drove it

  • New client wins, strong renewal retention, and expanded relationships with existing clients.
  • Continued flow into the specialty and E&S markets.
  • Modest amounts of revenue from acquisitions completed within the trailing twelve months ended September 30, 2026.
  • Growth across the majority of casualty lines.
  • General and administrative expense declined due to lower Acquisition-related expenses, partially offset by higher Restructuring and related expense due to the Empower Program.

Concerns

  • Organic Revenue Growth Rate was 4.0% in the quarter, compared to 15.0% in the prior-year period.
  • The Company experienced a moderate decline in its property portfolio.
  • Adjusted EBITDAC margin was 30.9%, compared to 31.2% in the prior-year period.
  • Compensation and benefits expense increased 9.9% to $484,208 (in thousands), exceeding total revenue growth of 4.7%.
  • Restructuring and related expense was $23,852 (in thousands) in the Adjusted EBITDAC reconciliation for the quarter due to the Empower Program.
  • Outstanding debt principal was $3.7 billion as of September 30, 2026.

What to watch

  • Organic Revenue Growth Rate relative to the full-year guidance of mid-single digits.
  • Adjusted EBITDAC Margin relative to guidance for a modest decline for 2026 compared to the prior year.
  • The property portfolio following the moderate decline reported in the third quarter.
  • Compensation and benefits expense and the compensation and benefits expense ratio.
  • The cost, timing and effects of the Empower Program.
  • Share repurchases under the $150.0 million remaining authorization.

Balance sheet and cash flow

  • Cash and cash equivalents of $168.8 million as of September 30, 2026.
  • Outstanding debt principal of $3.7 billion as of September 30, 2026.
  • Cash and cash equivalents were $168,811 (in thousands) at September 30, 2026, compared to $158,322 (in thousands) at December 31, 2025.
  • Long-term debt was $3,634,056 (in thousands) at September 30, 2026, compared to $3,291,462 (in thousands) at December 31, 2025.
  • Total cash flows provided by operating activities were $306,933 (in thousands) for the nine months ended September 30, 2026, compared to $380,421 (in thousands) in the prior-year period.
  • Capital expenditures were $(52,233) (in thousands) for the nine months ended September 30, 2026, compared to $(50,678) (in thousands) in the prior-year period.
  • Repurchases of Class A common stock were $(450,253) (in thousands) for the nine months ended September 30, 2026.

Analysis

Ryan Specialty reported third-quarter total revenue of $789,963 (in thousands), up 4.7% from $754,577 (in thousands). Net commissions and fees increased 4.8% to $775,081 (in thousands), while fiduciary investment income was $14,882 (in thousands), compared with $15,025 (in thousands). Organic Revenue Growth Rate was 4.0%, down from 15.0% in the prior-year period. Management attributed growth to new client wins, renewal retention, expanded client relationships, specialty and E&S market flow, and modest acquisition revenue. Growth occurred across the majority of casualty lines, while the property portfolio declined moderately.

All three reported specialties expanded in the quarter. Wholesale Brokerage net commissions and fees grew 4.6% to $394,283 (in thousands), Binding Authority increased 3.8% to $93,012 (in thousands), and Underwriting Management rose 5.4% to $287,786 (in thousands). Net commissions and policy fees increased 7.8% to $725,761 (in thousands), and supplemental and contingent commissions increased 13.4% to $33,781 (in thousands). These gains were partly offset by a 57.8% decline in loss mitigation and other fees to $15,539 (in thousands).

Profitability showed a sharp improvement in GAAP net income but a modest decline in the adjusted margin. Total operating expenses increased 0.8% to $649,135 (in thousands), with general and administrative expense down 9.0% but compensation and benefits up 9.9%. Operating income increased 27.1% to $140,828 (in thousands) and net income increased 40.6% to $88,048 (in thousands). Adjusted EBITDAC increased 3.8% to $244,446 (in thousands), but Adjusted EBITDAC margin declined to 30.9% from 31.2%. Adjusted net income increased 4.1% to $137,121 (in thousands), while adjusted net income margin was 17.4% versus 17.5%. Adjusted diluted earnings per share rose 8.5% to $0.51.

For the nine months ended September 30, 2026, total revenue increased 8.8% to $2,501,839 (in thousands), Adjusted EBITDAC increased 7.9% to $803,383 (in thousands), and net income increased 29.6% to $237,026 (in thousands). Operating cash flow was $306,933 (in thousands), compared with $380,421 (in thousands) in the prior-year period, while capital expenditures were $(52,233) (in thousands). The Company returned approximately $173.7 million in the third quarter and repurchased $450,253 (in thousands) of Class A common stock over the first nine months. It ended the quarter with cash and cash equivalents of $168.8 million and outstanding debt principal of $3.7 billion.

The Company maintained full-year guidance for Organic Revenue Growth Rate in the mid-single digits and guided to an Adjusted EBITDAC Margin down modestly from the prior year. The principal reported execution items are sustaining organic growth in an increasingly challenging market, managing compensation and restructuring costs under the Empower Program, and preventing further margin erosion. The moderate decline in property and the lower quarterly organic growth rate are also key demand and mix indicators.

Management, verbatim

We are proud of our third quarter performance, in light of an increasingly challenging market and against our toughest year over year comparison.

Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty

We grew total revenue 4.7%, driven by organic growth of 4.0%. We grew Adjusted EBITDAC by 3.8% and Adjusted Diluted EPS by 8.5%.

Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty

Our team delivered in the face of one of the most challenging markets we have ever seen, retaining high levels of existing business, winning significant new business, and building our pipelines.

Timothy W. Turner, Chief Executive Officer of Ryan Specialty

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided, so comparison of actual results with prior guidance is unavailable.
  • Gross margin was not reported.
  • Free cash flow was not reported.
  • A GAAP total revenue growth outlook was not provided.
  • A GAAP net income margin outlook was not provided.
  • A tax-rate outlook was not provided.
  • Prior-quarter comparisons were not reported for the presented key metrics.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Second Quarter 2026

AlphAI · Earnings readRYAN · Second Quarter 2026 · ended June 30, 2026

Total Revenue grew 7.2% year-over-year to $916.6 million; Adjusted EBITDAC grew 6.0% year-over-year to $326.9 million; Adjusted Diluted Earnings Per Share grew 12.1% to $0.74.

→Mixed quarter

Revenue, organic growth, Adjusted EBITDAC, adjusted net income and adjusted diluted earnings per share increased year-over-year, while GAAP operating income, net income and diluted earnings per share declined as operating expenses increased faster than revenue.

Revenue
$917M
7.2% y/y
Wholesale Brokerage
$499M
4.5% y/y
EPS · non-GAAP
$0.74
12.1% y/y

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Total revenueGAAP$916.6M–7.2%
Net commissions and feesGAAP$902.7M–7.4%
Compensation and benefitsGAAP$531.6M–9.6%
General and administrativeGAAP$118.6M–10.8%
Total operating expensesGAAP$736.3M–10.9%
Operating incomeGAAP$180.3M–(5.6%)
Net incomeGAAP$108.4M–(13.1%)
Net income attributable to Ryan Specialty Holdings, Inc.GAAP$42.31M–(18.6%)
Earnings per shareGAAP$0.34––
Diluted earnings per shareGAAP$0.33––
Compensation and benefits expense ratioGAAP58.0%––
General and administrative expense ratioGAAP12.9%––
Net income marginGAAP11.8%––
Organic revenue growth ratenon-GAAP6.7%––
Adjusted compensation and benefits expensenon-GAAP$494.9M–9.2%
Adjusted compensation and benefits expense rationon-GAAP54.0%––
Adjusted general and administrative expensenon-GAAP$94.80M–1.6%
Adjusted general and administrative expense rationon-GAAP10.3%––
Adjusted EBITDACnon-GAAP$326.9M–6.0%
Adjusted EBITDAC marginnon-GAAP35.7%––
Adjusted net incomenon-GAAP$198.7M–7.6%
Adjusted net income marginnon-GAAP21.7%––
Adjusted diluted earnings per sharenon-GAAP$0.74–12.1%
Net commissions and policy feesGAAP$852.4M–8.3%
Supplemental and contingent commissionsGAAP$32.17M–(9.7%)
Loss mitigation and other feesGAAP$18.18M–0.1%

Segments

SegmentRevenueq/qy/y
Wholesale BrokerageGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$498.8M–4.5%
Binding AuthorityGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$100.2M–6.0%
Underwriting ManagementGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth.$303.8M–12.8%

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Capital returns

  • Returned approximately $284.5 million to shareholders through $260.0 million of Class A common stock repurchases, representing 8.1 million shares, and $24.5 million in dividends and distributions.
  • As of June 30, 2026, the Company had $300.0 million of remaining authorization under its share repurchase authorization.
  • Expanded its repurchase authorization by an additional $300 million.

What drove it

  • Total revenue growth was driven by continued organic revenue growth of 6.7%, new client wins, strong renewal retention, expanded relationships with existing clients, continued flow into the specialty and E&S markets, and modest amounts of revenue from acquisitions completed within the trailing twelve months ended June 30, 2026.
  • The Company experienced growth across the majority of its casualty lines, offset by a moderate decline in its property portfolio.
  • Adjusted EBITDAC growth was driven primarily by strong revenue growth, partially offset by higher Adjusted compensation and benefits expense and Adjusted general and administrative expense.
  • Net commissions and policy fees increased 8.3%, while supplemental and contingent commissions declined 9.7%.

Concerns

  • Total operating expenses increased 10.9%, exceeding total revenue growth of 7.2%.
  • GAAP operating income decreased 5.6%, net income decreased 13.1%, and net income attributable to Ryan Specialty Holdings, Inc. decreased 18.6%.
  • Net income declined primarily because of higher Total operating expenses and higher Income tax expense, partially offset by strong revenue growth.
  • Adjusted EBITDAC margin declined to 35.7% from 36.1%, while the compensation and benefits expense ratio increased to 58.0% from 56.7%.
  • The Company reported a moderate decline in its property portfolio.

What to watch

  • Organic revenue growth rate was 6.7%, compared to 7.1% in the prior-year period.
  • Underwriting Management net commissions and fees grew 12.8%, compared with 4.5% for Wholesale Brokerage and 6.0% for Binding Authority.
  • Costs linked to headcount and revenue growth, Restructuring and related expense due to the Empower Program, change in contingent consideration, and Income tax expense.
  • Use of the remaining $300.0 million share repurchase authorization and the impact of capital returns alongside $3.6 billion of outstanding debt principal.

Balance sheet and cash flow

  • As of June 30, 2026, Cash and cash equivalents were $140.1 million.
  • As of June 30, 2026, outstanding debt principal was $3.6 billion.

Analysis

Ryan Specialty reported second-quarter total revenue of $916.6 million, up 7.2% year-over-year, supported by 6.7% organic revenue growth. Management attributed growth to new client wins, strong renewal retention, expanded existing-client relationships, continued flow into specialty and E&S markets, and modest revenue from trailing-twelve-month acquisitions. Growth occurred across the majority of casualty lines, while the property portfolio recorded a moderate decline.

Specialty mix favored Underwriting Management, where net commissions and fees increased 12.8% to $303,756 (in thousands). Binding Authority increased 6.0% to $100,170 (in thousands), and Wholesale Brokerage increased 4.5% to $498,802 (in thousands). Revenue by type showed net commissions and policy fees up 8.3%, while supplemental and contingent commissions declined 9.7%.

Profitability was pressured on a GAAP basis. Total operating expenses rose 10.9% to $736.3 million, outpacing revenue growth, as compensation and benefits, general and administrative expense, restructuring and related expense due to the Empower Program, and change in contingent consideration increased. GAAP operating income declined 5.6%, net income declined 13.1% to $108.4 million, and diluted earnings per share was $0.33. The reported net income decline also reflected higher Income tax expense.

Non-GAAP results remained positive but showed modest margin pressure. Adjusted EBITDAC increased 6.0% to $326.9 million, while Adjusted EBITDAC margin declined to 35.7% from 36.1%. Adjusted net income increased 7.6% to $198.7 million and Adjusted diluted earnings per share increased 12.1% to $0.74. The difference between GAAP and adjusted earnings outcomes makes operating-expense and tax items central to the period's result.

Capital allocation was substantial during the quarter, with approximately $284.5 million returned to shareholders, including $260.0 million of Class A common stock repurchases representing 8.1 million shares and $24.5 million in dividends and distributions. Cash and cash equivalents were $140.1 million and outstanding debt principal was $3.6 billion as of June 30, 2026. The filing did not provide forward guidance, so the next reported evidence on organic growth, property trends, expense growth, margins and repurchase deployment will be important.

Management, verbatim

We grew total revenue 7.2%, driven primarily by organic growth of 6.7%. We grew Adjusted EBITDAC by 6.0% and Adjusted Diluted EPS by 12.1%.

Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty

We also continued to return capital to shareholders through our dividend, repurchasing shares worth $260 million during the quarter, and expanding our repurchase authorization by an additional $300 million.

Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty

Positioned at the top of both specialty distribution and underwriting, the platform we've built over the past 16 years enables us to anticipate, identify, and meet the most pressing needs of our clients, even in the most challenging environments.

Timothy W. Turner, Chief Executive Officer of Ryan Specialty

Not in the filing

stated, not guessed
  • Forward revenue guidance
  • Forward gross margin guidance
  • Forward operating expenses guidance
  • Forward tax rate guidance
  • Other forward guidance
  • Previous-period outlook for comparison
  • Gross profit
  • Gross margin
  • Operating cash flow
  • Free cash flow
  • Prior-quarter comparisons for reported metrics
  • GAAP diluted earnings per share year-over-year change

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about RYAN earnings dates

When is Ryan Specialty Holdings's next earnings date?
AlphAI has no date for RYAN yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.